Purchase Order 75N93020P01014
Award Date 8/3/20
Potential Completion Date 8/2/21
Potential Value $147K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Potomac, MD 20854, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute awarded a firm fixed price purchase order contract to Speed Biosystems, LLC, a minority-owned small disadvantaged business, for the procurement of 70 units of TURBO293 Transfection Reagent (20ML). The $146,750.00 contract is to support coronavirus-related research and vaccine production for human clinical trials at NIH facilities in Bethesda and Rockville, Maryland. The contract was...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a firm fixed price purchase order to Speed Biosystems, LLC, a minority-owned, small disadvantaged business, for the provision of TURBO293 transfection reagents. The $146,750.00 contract is for the delivery of 70 units of the TURBO293 transfection reagent (20ml) to support coronavirus-related research at NIH labs and the Vaccine Research Center. This sole-source award was granted to Speed...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed price purchase order to Speed Biosystems, LLC, a minority-owned small disadvantaged business, to procure 50 units of the TURBO293 Transfection Reagent for $146,600.00. The award was made on a sole-source basis, as Speed Biosystems is the proprietary developer of the TURBO293 reagents, which are used in vaccine production for human clinical trials....
- The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases (NIH NIAID) awarded a $683,400.00 firm fixed price purchase order contract to Speed Biosystems, LLC, a minority-owned small disadvantaged business, for the provision of TURBO293 transfection reagents, kits, protocols, and continuity support. The contract, which did not involve set-asides or subcontractors, was sole-sourced to Speed Biosystems as the proprietary...
- The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm fixed-price purchase order contract to Speed Biosystems, LLC, a minority-owned small disadvantaged business, to provide 70 units of TURBO293 transfection reagent at a potential value of $146,750.00. The contract supports COVID-19 research and vaccine production activities at NIH labs in Maryland. This sole-source award was made under the...
- This contract is a firm fixed price purchase order awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Speed Biosystems, LLC, a minority-owned small disadvantaged business, for the provision of TURBO293 transfection reagents. The potential value of the contract is $146,750.00. The contract was sole-sourced to Speed Biosystems as the proprietary developer of the TURBO293 reagents, which...
- The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm fixed price purchase order to Speed Biosystems, LLC, a minority-owned small disadvantaged business, for the provision of TURBO293 AB Transfection Kit (for 20L culture) and TURBO293 Transfection Reagent (20ml). The $197,020.00 award did not involve any set-aside programs and is intended to support coronavirus-related research at NIH labs and the...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm fixed price purchase order contract to Speed Biosystems, LLC, a minority-owned small disadvantaged business. The $146,788.00 contract is for the provision of TURBO293 transfection reagents, kits, protocols, and continuity support to aid coronavirus-related research at NIH labs and the Vaccine Research Center. The contract has a...
- This is a firm fixed price purchase order contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Speed Biosystems, LLC, a minority-owned, small disadvantaged business, for the provision of TURBO293 transfection reagents, kits, protocols, and continuity support to aid coronavirus-related research at NIH labs and the Vaccine Research Center. The $146,600.00 contract was...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed price purchase order contract to Speed Biosystems, LLC, a minority-owned small disadvantaged business, for the provision of TURBO293 transfection reagents to support coronavirus-related research. The contract, valued at $148,325.00, does not have a set-aside designation. Speed Biosystems has received over $3 million in prime federal contracts from...
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute (NCI) awarded a firm fixed price purchase order to Speed Biosystems, LLC, a minority-owned small disadvantaged business, for the provision of 70 units of TURBO293 transfection reagent at a potential value of $146,750.00. The contract was awarded on a sole-source basis to Speed Biosystems as the proprietary developer of the TURBO293 reagents, which are used in vaccine production for human clinical trials by NIH's National Institute of Allergy and Infectious Diseases (NIAID). The contract does not have a set-aside designation, and delivery is to take place in Bethesda and Rockville, Maryland locations over a 12-month period.
Generated 3/21/24, 5:52 PM
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Turbo293 Transfection Reagent Speed Biosystems | NOI-NIAID-2029186 | Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases | Pre-Solicitation 1/1 | 7/24/20, 6:17 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Close Out | $0 | 12/1/20 | |
| Not listed | Not listed | $146.8k | 8/3/20 |